CABDX
Price
$7.29
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
VIVIX
Price
$69.87
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Ad is loading...

CABDX vs VIVIX

Header iconCABDX vs VIVIX Comparison
Open Charts CABDX vs VIVIXBanner chart's image
AB Relative Value A
Price$7.29
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
CABDX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CABDX vs. VIVIX commentary
Nov 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABDX is a StrongBuy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. CABDX (2.04B). VIVIX pays higher dividends than CABDX: VIVIX (2.37) vs CABDX (1.18). CABDX was incepted earlier than VIVIX: CABDX (92 years) vs VIVIX (26 years). CABDX is a more actively managed with annual turnover of: 77.00 vs. VIVIX (10.00). CABDX has a lower initial minimum investment than VIVIX: CABDX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 30.20 vs. CABDX (23.14). VIVIX return over 5 years is better than : 54.44 vs. CABDX (34.23).
CABDXVIVIXCABDX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence92 years26 years-
Gain YTD19.50819.93098%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B184B1%
Annual Yield % from dividends1.182.3750%
Returns for 1 year23.1430.2077%
Returns for 3 years3.6423.4715%
Returns for 5 years34.2354.4463%
Returns for 10 years37.21115.5232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFSLX29.780.51
+1.74%
1919 Financial Services C
JSECX26.880.17
+0.64%
JPMorgan Small Cap Equity C
BOPAX29.690.11
+0.37%
Sterling Capital Special Opps A
PHPSX24.34N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc
CPOCX14.24N/A
N/A
Morgan Stanley Insight L